ABBV
Price
$194.29
Change
-$1.16 (-0.59%)
Updated
Oct 4 closing price
20 days until earnings call
LLY
Price
$885.55
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
26 days until earnings call
Ad is loading...

ABBV vs LLY

Header iconABBV vs LLY Comparison
Open Charts ABBV vs LLYBanner chart's image
ABBVIE
Price$194.29
Change-$1.16 (-0.59%)
Volume$4.75M
CapitalizationN/A
Eli Lilly & Co
Price$885.55
Change-$0.00 (-0.00%)
Volume$1.97M
CapitalizationN/A
View a ticker or compare two or three
ABBV vs LLY Comparison Chart
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABBV vs. LLY commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Buy and LLY is a Buy.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (ABBV: $195.45 vs. LLY: $885.55)
Brand notoriety: ABBV and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 76% vs. LLY: 63%
Market capitalization -- ABBV: $322.43B vs. LLY: $739.66B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. LLY’s [@Pharmaceuticals: Major] market capitalization is $739.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 5 FA rating(s) are green whileLLY’s FA Score has 3 green FA rating(s).

  • ABBV’s FA Score: 5 green, 0 red.
  • LLY’s FA Score: 3 green, 2 red.
According to our system of comparison, ABBV is a better buy in the long-term than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 2 TA indicator(s) are bullish while LLY’s TA Score has 3 bullish TA indicator(s).

  • ABBV’s TA Score: 2 bullish, 6 bearish.
  • LLY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ABBV and LLY are a bad buy in the short-term.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +1.85% price change this week, while LLY (@Pharmaceuticals: Major) price change was -2.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.46%. For the same industry, the average monthly price growth was -2.75%, and the average quarterly price growth was +6.52%.

Reported Earning Dates

ABBV is expected to report earnings on Oct 25, 2024.

LLY is expected to report earnings on Oct 30, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (-1.46% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($740B) has a higher market cap than ABBV($322B). LLY has higher P/E ratio than ABBV: LLY (131.13) vs ABBV (66.46). LLY YTD gains are higher at: 52.655 vs. ABBV (28.926). ABBV has higher annual earnings (EBITDA): 17.2B vs. LLY (8.57B). ABBV has more cash in the bank: 12.8B vs. LLY (2.93B). LLY has less debt than ABBV: LLY (25.2B) vs ABBV (59.4B). ABBV has higher revenues than LLY: ABBV (54.3B) vs LLY (34.1B).
ABBVLLYABBV / LLY
Capitalization322B740B44%
EBITDA17.2B8.57B201%
Gain YTD28.92652.65555%
P/E Ratio66.46131.1351%
Revenue54.3B34.1B159%
Total Cash12.8B2.93B437%
Total Debt59.4B25.2B236%
FUNDAMENTALS RATINGS
ABBV vs LLY: Fundamental Ratings
ABBV
LLY
OUTLOOK RATING
1..100
6570
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
1918
PRICE GROWTH RATING
1..100
2448
P/E GROWTH RATING
1..100
1129
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABBV's Valuation (21) in the Pharmaceuticals Major industry is significantly better than the same rating for LLY (92). This means that ABBV’s stock grew significantly faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (2) in the Pharmaceuticals Major industry is in the same range as ABBV (3). This means that LLY’s stock grew similarly to ABBV’s over the last 12 months.

LLY's SMR Rating (18) in the Pharmaceuticals Major industry is in the same range as ABBV (19). This means that LLY’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's Price Growth Rating (24) in the Pharmaceuticals Major industry is in the same range as LLY (48). This means that ABBV’s stock grew similarly to LLY’s over the last 12 months.

ABBV's P/E Growth Rating (11) in the Pharmaceuticals Major industry is in the same range as LLY (29). This means that ABBV’s stock grew similarly to LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVLLY
RSI
ODDS (%)
Bearish Trend 2 days ago
48%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
40%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 5 days ago
59%
Bullish Trend 10 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 8 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
33%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Ad is loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSGN5.000.28
+5.93%
Design Therapeutics
NXTC1.350.04
+3.05%
NextCure
THG149.033.12
+2.14%
Hanover Insurance Group (The)
CMCO34.830.41
+1.19%
Columbus McKinnon Corp
SRE82.600.07
+0.08%
Sempra

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-0.59%
PFE - ABBV
54%
Loosely correlated
+0.85%
JNJ - ABBV
45%
Loosely correlated
-0.13%
AMGN - ABBV
36%
Loosely correlated
+0.69%
GSK - ABBV
36%
Loosely correlated
+1.17%
NVS - ABBV
35%
Loosely correlated
+0.16%
More

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with NVS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-0.62%
NVS - LLY
42%
Loosely correlated
-0.61%
OGN - LLY
25%
Poorly correlated
-1.72%
JNJ - LLY
21%
Poorly correlated
-0.42%
ABBV - LLY
21%
Poorly correlated
-0.70%
PFE - LLY
20%
Poorly correlated
-0.94%
More